Market Movers

Walgreens Boots Alliance, Inc.’s Stock Price Dips to $9.80, Marking a 4.66% Decline: Is it Time to Buy?

By February 4, 2025 No Comments

Walgreens Boots Alliance, Inc. (WBA)

9.80 USD -0.48 (-4.66%) Volume: 25.54M

Walgreens Boots Alliance, Inc.’s stock price is currently trading at 9.80 USD, witnessing a dip of -4.66% this trading session with a trading volume of 25.54M. Despite the recent fall, the stock maintains a positive year-to-date (YTD) percentage change of +5.05%, highlighting its potential for steady growth.


Latest developments on Walgreens Boots Alliance, Inc.

Today, Walgreens Boots Alliance stock price experienced significant movements following a series of key events. Swedbank AB purchased a substantial number of shares, while the company announced the suspension of its quarterly dividend as part of a turnaround strategy. This decision, along with facing legal challenges and a securities class action lawsuit, led to a market plunge and analysts downgrading the stock. Investors with substantial losses were urged to consider participating in a class action lawsuit. With the dividend streak of 92 years being suspended, investors are left questioning the future prospects of Walgreens Boots Alliance amidst these challenges.


Walgreens Boots Alliance, Inc. on Smartkarma

Analysts on Smartkarma, such as Baptista Research, have been closely covering Walgreens Boots Alliance, a retail pharmacy giant. In their research reports like “Walgreens Boots Alliance: An Insight Into Its Procurement Optimization,” analysts discuss the company’s mixed financial and strategic performance. They highlight the company’s efforts in optimizing its store footprint and turnaround strategy for its U.S. Retail Pharmacy business, which have shown positive early results.

Another report by Baptista Research titled “Walgreens Buyout Buzz: Why Sycamore Partners May Bet Big on the Struggling Pharmacy Giant!” explores potential buyout discussions between Walgreens Boots Alliance and Sycamore Partners. The report mentions the surge in Walgreens’ shares following reports of these talks amidst a challenging business environment marked by margin pressures and rising operating costs. Analysts are closely monitoring these developments to evaluate the impact on the company’s future performance and valuation.


A look at Walgreens Boots Alliance, Inc. Smart Scores

FactorScoreMagnitude
Value5
Dividend5
Growth2
Resilience2
Momentum4
OVERALL SMART SCORE3.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Walgreens Boots Alliance, Inc. has received high scores in Value and Dividend from Smartkarma Smart Scores, indicating a positive long-term outlook for the company in terms of its financial health and ability to provide returns to investors. However, the company scored lower in Growth and Resilience, suggesting potential challenges in expanding its business and navigating through unpredictable market conditions. With a moderate score in Momentum, Walgreens Boots Alliance shows promising signs of market performance in the near future.

Operating retail drugstores with a wide range of healthcare and general products, Walgreens Boots Alliance, Inc. offers various health services to its customers. With a strong focus on value and dividends, the company aims to provide quality products and returns to its stakeholders. Despite facing some growth and resilience challenges, Walgreens Boots Alliance continues to strive for success in the competitive market, supported by its momentum score indicating positive market performance ahead.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars